Poly(ADP-ribose) polymerase inhibition by genetic and pharmacological means

Cell Death: The Role of Poly (ADP-ribose) Polymerase

Volumn , Issue , 2000, Pages 279-304

  Zhang, Jie ^a   Li, Jia He ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992606143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038897     Document Type: Chapter

References (120)

1. de Murcia, G. and Ménissier-de Murcia, J., Poly(ADP-ribose) polymerase: a molecular nick-sensor, Trends Biochem. Sci., 19, 172, 1994.
2. Ueda, K. and Hayaishi, O., ADP-ribosylation, Annu. Rev. Biochem., 54, 73, 1985.
3. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C., Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE, Nature, 371, 346, 1994.
4. Banasik, M., Komura, H., Shimoyama, M., and Ueda, K., Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase, J. Biol. Chem., 267, 1569, 1992.
5. Milam, K. M. and Cleaver, J. E., Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes, Science, 223, 589, 1984.
6. Ruf, A., Ménissier-de Murcia, J., de Murcia, G., and Schulz, G. E., Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken, Proc. Natl. Acad. Sci. U.S.A., 93, 7481, 1996.
7. Zhang, J., PARP inhibition: a novel approach to treat ischaemia/reperfusion and inflammation-related injuries, in Emerging Drugs: The Prospect for Improved Medicines, Vol. 4, Fitzgerald, J. D., Bowman, W. C., and Taylor, J. B., Eds., Ashley Publication Ltd., London, 1999, chap. 10.
8. LaPlaca, M. C., Zhang, J., Li, J.-H., Raghupathi, R., Smith, F., Bareye, F. M., Graham, D. I., and McIntosh, T. K., Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats, in 19th Annual Neurotrauma Society Symposium, Miami, Florida, J. Neurotrauma, 16, 976, 1999 (abstract).
9. Zhang, J., Li, J.-H., Lautar, S., Zhou, Y., Mooney, M. L., and Williams, L. R., GPI 6150, a PARP inhibitor, exhibits strong anti-inflammatory effect in rat models of arthritis, in 6th International Meeting of Biology of Nitric Oxide, Stockholm, Sweden, Acta. Physiol. Scand., 167(Suppl.), 90, 1999 (abstract).
10. Szabó, C. and Dawson, V. L., Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion, Trends Pharmacol. Sci., 19, 287, 1998.
11. Whalen, M. J., Clark, R. S. B., Dixon, C. E., Robinchaud, P., Marion, D. W., Vagni, V., Graham, S. H., Virág, L., Hasko, G., Stachlewitz, R., Szabó, C., and Kochanek, P. M., Reduction of cognitive and motor deficits after traumatic brain injury in mice dificient in poly(ADP-ribose) polymerase, J. Cereb. Blood Flow Metab., 19, 835, 1999.
12. Kumari, S. R., Mendoza-Alvarez, H., and Alvarez-Gonzalez, R., Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the Mr 85,000 proteolytic fragment, Cancer Res., 58, 5075, 1998.
13. Simbulan-Rosenthal, C. M., Rosenthal, D. S., Luo, R., and Smulson, M. E., Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells, Cancer Res., 59, 2190, 1999.
14. Uchida, K. and Miwa, M., Poly(ADP-ribose) polymerase: structural conservation among different classes of animals and its implications, Mol. Cell. Biochem., 138, 25, 1994.
15. Tseng, A., Jr., Lee, W. M., Jakobovits, E. B., Kirsten, E., Hakam, A., McLick, J., Buki, K., and Kun, E., Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase, Proc. Natl. Acad. Sci. U.S.A., 84, 1107, 1987.
16. Simonin, F., Ménissier-de Murcia, J., Poch, O., Muller, S., Gradwohl, G., Molinete, M., Penning, C., Keith, G., and de Murcia, G., Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity, J. Biol. Chem., 265, 19249, 1990.
17. Simonin, F., Poch, O., Delarue, M., and de Murcia, G., Identification of potential active-site residues in the human poly(ADP-ribose) polymerase, J. Biol. Chem., 268, 8529, 1993.
18. Ruf, A., de Murcia, G., and Schulz, G. E., Inhibitor and NAD+ binding to poly(ADPribose) polymerase as derived from crystal structures and homology modeling, Biochemistry, 37, 3893, 1998.
19. Berger, N. A., Poly(ADP-ribose) in the cellular response to DNA damage, Radiat. Res., 101, 4, 1985.
20. Yamamoto, H. and Okamoto, H., Protection by picolinamide, a novel inhibitor of poly(ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets, Biochem. Biophys. Res. Commun., 95, 474, 1980.
21. Endres, M., Wang, Z. Q., Namura, S., Waeber, C., and Moskowitz, M. A., Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase, J. Cereb. Blood Flow Metab., 17, 1143, 1997.
22. Wielckens, K., Schmidt, A., George, E., Bredehorst, R., and Hilz, H., DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADPribosyl) and poly(ADP-ribosyl) proteins, J. Biol. Chem., 257, 12872, 1983.
23. Ding, R., Pommier, Y., Kang, V. H., and Smulson, M. E., Depletion of poly(ADPribose) polymerase by antisense RNA expression results in a delay in DNA strand break rejoining, J. Biol. Chem., 267, 12804, 1992.
24. Ding, R. and Smulson, M. E., Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: influences on genomic stability, chromatin organization, and carcinogen cytotoxicity, Cancer Res., 54, 4627, 1994.
25. Qu, Z., Fujimoto, S., and Taniguchi, T., Enhancement of interferon-gamma-induced major histocompatibility complex class II gene expression by expressing an antisense RNA of poly(ADP-ribose) synthetase, J. Biol. Chem., 269, 5543, 1994.
26. Babiychuk, E., Cottrill, P. B., Storozhenko, S., Fuangthong, M., Chen, Y., O’Farrell, M. K., Van Montagu, M., Inze, D., and Kushnir, S., Higher plants possess two structurally different poly(ADP-ribose) polymerases, Plant J., 15, 635, 1998.
27. Berghammer, H., Ebner, M., Marksteiner, R., and Auer, B., pADPRT-2: a novel mammalian polymerizing(ADP-ribosyl)transferase gene related to truncated pADPRT homologues in plants and Caenorhabditis elegans, FEBS Lett., 449, 259, 1999.
28. Johansson, M., A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues, Genomics, 57, 442, 1999.
29. Ame, J. C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., Muller, S., Hoger, T., Ménissier-de Murcia, J., and de Murcia, G., PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase, J. Biol. Chem., 274, 17860, 1999.
30. Le Cam, E., Fack, F., Ménissier-de Murcia, J., Cognet, J. A., Barbin, A., Sarantoglou, V., Revet, B., Delain, E., and de Murcia, G., Conformational analysis of a 139 basepair DNA fragment containing a single-stranded break and its interaction with human poly(ADP-ribose) polymerase, J. Mol. Biol., 235, 1062, 1994.
31. Molinete, M., Vermeulen, W., Burkle, A., Ménissier-de Murcia, J., Kupper, J. H., Hoeijmakers, J. H., and de Murcia, G., Overproduction of the poly(ADP-ribose) polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in mammalian cells, EMBO J., 12, 2109, 1993.
32. Kupper, J. H., van Gool, L., and Burkle, A., Molecular genetic systems to study the role of poly(ADP-ribosyl)ation in the cellular response to DNA damage, Biochimie, 77, 450, 1995.
33. Kupper, J. H., Muller, M., Jacobson, M. K., Tatsumi-Miyajima, J., Coyle, D. L., Jacobson, E. L., and Burkle, A., trans-Dominant inhibition of poly(ADP-ribosyl)ation sensitizes cells against gamma-irradiation and N-methyl-N′-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyomavirus replicon, Mol. Cell. Biol., 15, 3154, 1995.
34. Schreiber, V., Hunting, D., Trucco, C., Gowans, B., Grunwald, D., de Murcia, G., and Ménissier-de Murcia, J., A dominant-negative mutant of human poly(ADPribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage, Proc. Natl. Acad. Sci. U.S.A., 92, 4753, 1995.
35. Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., and Wagner, E. F., Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease, Genes Dev., 9, 509, 1995.
36. de Murcia, J. M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F. J., Masson, M., Dierich, A., LeMeur, M., Walztinger, C., Chambon, P., and de Murcia, G., Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells, Proc. Natl. Acad. Sci. U.S.A., 94, 7303, 1997.
37. Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K., Watanabe, T., Sugimoto, T., Nakagama, H., Ochiya, T., and Sugimura, T., Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes, Proc. Natl. Acad. Sci. U.S.A., 96, 2301, 1999.
38. Attardi, L. D. and Jacks, T., The role of p53 in tumour suppression: lessons from mouse models, Cell. Mol. Life Sci., 55, 48, 1999.
39. Wang, Z. Q., Stingl, L., Morrison, C., Jantsch, M., Los, M., Schulze-Osthoff, K., and Wagner, E. F., PARP is important for genomic stability but dispensable in apoptosis, Genes Dev., 11, 2347, 1997
40. Leist, M., Single, B., Kunstle, G., Volbracht, C., Hentze, H., and Nicotera, P., Apoptosis in the absence of poly-(ADP-ribose) polymerase, Biochem. Biophys. Res. Commun., 233, 518, 1997.
41. Trucco, C., Oliver, F. J., de Murcia, G., and Ménissier-de Murcia, J., DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines, Nucl. Acids Res., 26, 2644, 1998.
42. Masutani, M., Nozaki, T., Nishiyama, E., Shimokawa, T., Tachi, Y., Suzuki, H., Nakagama, H., Wakabayashi, K., and Sugimura, T., Function of poly(ADP-ribose) polymerase in response to DNA damage: gene-disruption study in mice, Mol. Cell. Biochem., 193, 149, 1999.
43. Choi, D. W., At the scene of ischemic brain injury: is PARP a perp? Nat. Med., 3, 1073, 1997.
44. Eliasson, M. J., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z. Q., Dawson, T. M., Snyder, S. H., and Dawson, V. L., Poly(ADPribose) polymerase gene disruption renders mice resistant to cerebral ischemia, Nat. Med., 3, 1089, 1997.
45. Burkart, V., Wang, Z. Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., and Kolb, H., Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin, Nat. Med., 5, 314, 1999.
46. Pieper, A. A., Brat, D. J., Krug, D. K., Watkins, C. C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z. Q., and Snyder, S. H., Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes, Proc. Natl. Acad. Sci. U.S.A., 96, 3059, 1999.
47. Stone, P. R. and Shall, S., Poly(adenosine diphosphoribose) polymeraae in mammalian nuclei. Characterization of the activity in mouse fibroblasts (LS cells), Eur. J. Biochem., 38, 146, 1973.
48. Purnell, M. R. and Whish, W. J. D., Novel inhibitors of poly(ADP-ribose) synthetase, Biochem. J., 185, 775, 1980.
49. Durkacz, B. W., Omidiji, O., Gray, D. A., and Shall, S., (ADP-ribose)n participates in DNA excision repair, Nature, 283, 593, 1980.
50. Nishizuka, Y., Ueda, K., Nakazawa, K., Reeder, R. H., Honjo, T., and Hayaishi, O., Poly adenosine diphosphate ribose synthesis and nicotinamide adenine dinucleotide transglycosidases, J. Vitaminol., 14, 143, 1968.
51. Clark, J. B., Ferns, G. M., and Pinder, S., Inhibition of nuclear NAD nucleosidase and poly ADP-ribose polymerase activity from rat liver by nicotinamide and 5-methyl nicotinamide, Biochem. Biophys. Acta, 238, 82, 1971.
52. Preiss, I., Schlseger, R., and Hitz, H., Specific inhibition of poly ADP ribose polymerase by thymidine and nicotinamide in HeLa cells, FEBS Lett., 9, 244, 1971.
53. Uecia, K., Fukushima, M., Okaysma, H., and Havaishi, O., Nicotinamide adenine dinucleotide glycohydrolase from rat liver nuclei. Isolation and characterization of a new enzyme, J. Biol. Chem., 250, 7541, 1975.
54. Claycomb, W. C., Poly(adenosine diphosphate ribose) polymerase activity and nicotinamide adenine dinucleotide in differentiating cardiac muscles, Biochemistry, 1154, 387, 1976.
55. Levi, V., Jacobson, E. L., and Jacobson, M. K., Inhibition of poly(ADP-ribose) polymerase by methylated xanthines and cytokinins, FEBS Lett., 88, 144, 1978.
56. Terada, M., Fujiki, H., Marks, P. A., and Sugimura, T., Induction of erythroid differentiation of murine erythraleukernia cells by nicotinamide and related phosphate ribose) polymerase, Proc. Natl. Acad. Sci. U.S.A., 76, 6411, 1979.
57. Yaniamoto, H. and Okanioto, H., Protection by picolinamide, a novel inhibitor of poly(ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets, Biochem. Biophys. Res. Commun., 95, 474, 1980.
58. Oikawa, A., Tohua, H., Kanai, M., Miwa, M., and Sugimura, T., Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges, Biochem. Biophys. Res. Commun., 97, 1311, 1980.
59. Buki, K. G., Bauer, P. L., Mendeleyev, J., Hakam, A., and Kun, E., Destabilization of Zn2+ coordination in ADP-ribose transferase (polymerizing) by 6-nitroso 1,2-benzopyrone coincidental with inactivation of the polymerase but not the DNA binding function, FEBS Lett., 290 181, 1991.
60. Banasik, M. and Ueda, K., Inhibitors and activators of ADP-ribosylation reactions, Mol. Cell. Biochem., 138, 185, 1994.
61. Sims, J. L. and Benjamin, R. C., Mechanism of ethanol stimulation of poly(ADP ribose) synthetase, in ADP Ribosylation of Proteins, Althaus, F. R., Htlz, H., and Shall, S., Eds., Springer-Verlag, Berlin, 1985, 124-128.
62. Banasik, M. and Ueda, K., Dual inhibitory effects of dimethyl sulfoxoide on poly(ADP-ribose) synthetase, J. Enzyme Inhibition, 14, 239, 1999.
63. Rankin, P. W., Jacobson, E. L., Benjamin, R. C., Moss, I., and Jacobson, M. K., Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo, J. Biol. Chem., 264, 4312, 1989.
64. Borek, C., Morgan, W. F., Ong, A., and Cleaver, J. E., Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis, Proc. Natl. Acad. Sci. U.S.A., 81, 243, 1984.
65. Shinkwin, A. E., Whish, W. J. D., and Threadgill, M. D., Synthesis of thiophenecarboxamides, thieno[3,4-c]pyridin-4(5H)-ones and thieno[3,4-d]pyrimidin-4(3H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP), Bioorg. Med. Chem., 7, 297, 1999.
66. Sims, J. L., Sikorski, G. W., Catino, D. M., Berger, S. I., and Berger, N. A., Poly(adenosine diphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes, Biochemistry, 21, 1813, 1982.
67. Watson, C. Y., Whish, W. I. D., and Threadgill, M. D., Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP), Bioog. Med. Chem., 6, 721, 1998.
68. Griffin, R. J., Walk, L., Calvert, A. H., Curtin, N. J., Newell, D. R., and Golding, B. T., Benzamide analogs, useful as PARP (ADP-ribosyltransferase, ADPRT) DNA repair enzyme inhibitors, Int. Publication Number: WO/95/24379, 1995.
69. Suto, M. J., Turner, W. R., Arundel-Suto, C. K., Werbel, L. M., and Sebolt-Leopold, J. S., Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose)polymerase, Anti-Cancer Drug Design, 7, 101, 1991.
70. Banasik, M., Kornura, H., and Ueda, K., Inhibition of poly(ADP-ribose) synthetase by fatty acids, vitamins and vitamin-like substances, FEBS Lett., 263, 222, 1990.
71. Cleaver, J. E., Bodell, W. I., Morgan, W. E., and Zelle, B., Differences in regulation by poly(ADP-ribose) of repair of DNA damage from alkylating agents and ultraviolet light according to cell type, J. Biol. Chem., 258, 9059, 1983.
72. Cleaver, J. E., Differential toxicity of 3-aminobenzamide to wild-type and 6-thioguanine-resistant Chinese hamster cells by interference with pathways of purine biosynthesis, Mutat. Res., 131, 123, 1984.
73. Milam, K. M. and Cleaver, J. E., Inhibitors of poly(adenosine diphosphate-ribose) synthesis effect on other metabolic processes, Science, 223, 589, 1984.
74. Banasik, M., Komura, H., Shimoyama, M., and Ueda, K., Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase, J. Biol. Chem., 267, 1569, 1992.
75. Sestili, P., Spadons, G., Balsamini, C., Scovassi, I., Cattabeni, F., Duranti, E., Cantoni, O., Higgins, D., and Thomson, C., Structural requirements for inhibitor of poly(ADPribose) polymerase, J. Cancer Res. Clin. Oncol., 116, 615, 1990.
76. Bowman, K. J., Curtin, N. J., Golding, B. T., Griffn, R. J., and White, A., Potentiation of anticancer agent cytotoxicity by the novel poly(ADP-ribose) polymerase inhibitors, NU1025 and NU1064, Br. J. Cancer, 78, 1269, 1998.
77. Griffin, R. J., Srinivasan, S., White, A. W., Bowman, K., Calvert, A. H., Curtin, N. J., Newell, D. R., and Golding, B. T., Novel benzimidazole and quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase, Pharm. Sci., 2, 43, 1996.
78. Griffin, R. J., Srinivasan, S., Bowman, K., Calvert, A. H., Curtin, N. J., Newell, D. R., Pemberton, L. C., and Golding, B. T., Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP), J. Med. Chem., 41, 5247, 1998.
79. Showalter, H. D. H., Dihydro-and Tetrahydronaohthyridines, U.S. Patent 5,391,554, 1995.
80. Griffin, R. J., Pemberton, L. C., Rhodes, D., Blesadale, C., Bowman, K., Calvert, R. A. H., Cumin, N. J., Durkacz, B. W., Newell, D. B., Porteous, J. K., and Golding, B. T., Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP), Anti-Cancer Drug Design, 10, 507, 1995.
81. Yoshida, S., Aoyagi, T., Harada, S., Matuda, N., Ikeda, T., Naganawa, H., Hamada, M., and Takeuchi, T., Production of 2-methyl-4[3H]quinazolinone, an inhibitor of poly(ADP-ribose) synthetase, by bacterium, J. Antibiot., 44, 111, 1991.
82. Li, J-H., Tays, K. L., and Zhang, J., Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity, Int. Publication Number: WO/99/11624, 1999.
83. Li, J-H., Zhang, J., Jackson, P. F., and Maclin, K. M., Poly(ADP-ribose) polymerase (PARP) inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage, Int. Publication Number: WO/99/11645, 1999.
84. Zhang, J., Li, J-H., and Lautar, S., Post-ischemia protection by a potent PARP inhibitor in focal ischemia, Soc. Neurosci. Abstr., 24, 1226, 1998.
85. Benjamin, R. C. and Gill, D. M., Poly(ADP-ribose)synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks, J. Biol. Chem., 255, 10502, 1980.
86. Pivazyan, A. D., Birks, E. M., Wood, T. G., Lin, T. S., and Prusoff, W. H., Inhibition of poly(ADP-ribose) polymerase activity by nucleoside analogs of thymidine, Biochem. Pharmacol., 44, 947, 1992.
87. Kun, E., Methods for treating inflammation, inflammatory disease, arthritis and stroke using pADPT inhibitors, Int. Publication Number: WO/98/51307, 1998.
88. Endres, M., Scott, G. S., Salzman, A. L., Kun, E., Moskowitz, M. A., and Szabó, C., Protective effects of 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly(ADPribose) synthetase against peroxynitrite-induced glial damage and stroke development, Eur. J. Pharmacol., 351, 377, 1998.
89. Szabó, C., Virág, L., Cuzzocrea, S., Scott, G. S., Hake, P., O’Connor, M. P., Zingarelli, B., Salzman, A., and Kun, E., Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase, Proc. Natl. Acad. Sci. U.S.A., 95, 3867, 1998.
90. Banasik, M., Komura, H., and Ueda, K., Inhibitions of poly(ADP-ribose) synthetase by unsaturated fatty acids, vitamins and vitamin-like substances, FEBS Lett., 263, 222, 1990.
91. Vanni, A., Fiore, M., De Salvia, R., Cundari, E., Ricordy, R., Ceccarelli, R., and Degrassi, F., DNA damage and cytotoxicity induced by beta-lapachone: relation to poly(ADP-ribose) polymerase inhibition, Mutat. Res., 401, 55, 1998.
92. Yager, J. W. and Wienke, J. K., Inhibition of poly(ADP-ribose) polymerase by arsenite Mutat. Res., 386, 345, 1997.
93. Ueda, K., Banasik, M., Nakajima, S., Yook, H. Y., and Kido, T., Cell differentiation induced by poly(ADP-ribose) synthetase inhibitors, Biochimie, 77, 368, 1995.
94. Yoshida, S., Naganawa, H., Aoyagi, T., Takeuchi, T., and Umezawa, H., Benadrostin, new inhibitor of poly(ADP-ribose) synthetase, produced by actinomycetes. II. Structure determination, J. Antibiot., 41, 1015, 1998.
95. Nduka, N., Skidmore, C. J., and Shall, S., The enhancement of cytotoxicity of Nmethyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase, Eur. J. Biochem., 105, 525, 1980.
96. Ben-Hur, E., Utsumi, H., and Elkind, M. M., Inhibitors of poly(ADP-ribose) synthesis enhance X-ray killing of log-phase Chinese hamster cells, Radiat. Res., 97, 546, 1984.
97. Yamamoto, H., Uchigata, Y., and Okamoto, H., Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets, Nature, 294, 284, 1981.
98. Masiello, P., Cubeddu, T. L., Frosina, G., and Bergamini, E., Protective effect of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase, against streptozotocin-induced diabetes, Diabetologia, 28, 683, 1985.
99. Wallis, R. A., Panizzon, K. L., Henry, D., and Wasterlain, C. G., Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation, Neuroreport, 5, 245, 1999.
100. Zhang, J., Dawson, V. L., Dawson, T. M., and Snyder, S. H., Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity, Science, 263, 687, 1994.
101. Cosi, C., Suzuki, H., Milani, D., Facci, L., Menegazzi, M., Vantini, G., Kanai, Y., and Skaper, S. D., Poly(ADP-ribose) polymerase: early involvement in glutamateinduced neurotoxicity in cultured cerebellar granule cells, J. Neurosci. Res., 39, 38, 1994.
102. Zhang, J., Pieper, A., and Snyder, S. H., Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage, J. Neurochem., 65,1411, 1995.
103. Takahashi, K., Greenberg, J. H., Jackson, P., Maclin, K., and Zhang, J., Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats, J. Cereb. Blood Flow Metab., 17, 1137, 1997.
104. Lo, E. H., Bosque-Hamilton, P., and Meng, W., Inhibition of poly(ADP-ribose) polymerase reduction of ischemic injury and attenuation of N-methyl-D-aspartateinduced neurotransmitter dysregulation, Stroke, 29, 830, 1997.
105. Ayoub, I. A., Ogilvy, C. S., and Maynard, K. I., Nicotinamide reduces infarct in a permanent model of focal cerebral ischemia in Wistar rats, Soc. Neurosci. Abstr., 24, 214, 1998.
106. Tokime, T., Nozaki, K., Sugino, T., Kikuchi, H., Hashimoto, N., and Ueda, K., Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain, J. Cereb. Blood Flow Metab., 18, 991, 1998.
107. Sun, A.-Y. and Cheng, J.-S., Neuroprotective effects of poly(ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats, Acta Pharmacol. Sin., 19, 104, 1998.
108. Takahashi, K., Pieper, A. A., Croul, S. E., Zhang, J., Snyder, S. H., and Greenberg, J. H., Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia, Brain Res., 829, 46, 1999.
109. Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z. Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., and Dawson, T. M., Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism, Proc. Natl. Acad. Sci. U.S.A., 96, 5774, 1999.
110. Cosi, C. and Marien, M., Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADPribose) polymerase inhibitor, benzamide, Brain Res., 809, 58, 1998.
111. Thiemermann, C., Bowes, J., Myint, F. P., and Vane, J. R., Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle, Proc. Natl. Acad. Sci. U.S.A., 94, 679, 1997.
112. Zingarelli, B., Cuzzocrea, S., Zsengeller, Z., Salzman, A. L., and Szabó, C., Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase, Cardiovasc. Res., 36, 205, 1997.
113. Zingarelli, B., Salzman, A. L., and Szabó, C., Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury, Circ. Res., 83, 85, 1998.
114. Grupp, I. L., Jackson, T. M., Hake, P., Grupp, G., and Szabó, C., Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts, J. Mol. Cell. Cardiol., 31, 297, 1999.
115. Walles, T., Wang, P., Pieper, A., Li, J.-H., Zhang, J., Snyder, S. H., and Zweier, J. L., Mice lacking poly(ADP-ribose) polymerase gene show attenuated cellular energy depletion and improved recovery of myocardial function following global ischemia, Circ. Suppl., 98, I-260, 1998.
116. Szabó, C., Lim, L. H., Cuzzocrea, S., Getting, S. J., Zingarelli, B., Flower, R. J., Salzman, A. L., and Perretti, M., Inhibition of poly(ADP-ribose) synthetase attenuates neutrophil recruitment and exerts anti-inflammatory effects, J. Exp. Med., 186, 1041, 1997.
117. Zingarelli, B., Szabó, C., and Salzman, A. L., Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis, Gastroenterology, 116, 335, 1999.
118. Suto, M. J., Turner, W. R., and Werbel, L. M., Substituted Dihydroisoquinolinones and Related Compounds as Potentiators of the Lethal Effects of Radiation and Certain Chemotherapeutic Agents; Selected Compounds, Analogs and Process, U.S. Patent 5,177,075, 1993.
119. Griffin, R. J., Curtin, N. J., Newell, D. R., and Golding, B. T., Quinazolinone Compounds as Chemotherapeutic Agents, European Patent Application EP 0897915, 1999.
120. Griffin, R. J., Curtin, N. J., Newell, D. R., and Golding, B. T., Benzamide Analogues, Useful as PARP (ADP-Ribosyltransferas, ADPRT) DNA Repair Enzyme Inhibitors, European Patent Application EP 0879820, 1998.